The accepted paper, titled "Evaluation of Urcosimod in Neuropathic Corneal Pain: Efficacy and Safety Results from a Proof-of-Concept Pilot Phase 2 Study", will be presented in the Ocular Surface ...
A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing complex symptoms and treatment challenges. Discover her journey and management strategies. Dr. Shune discusses how ...
The Pathways Home, also called the SLO County Behavioral Health Continuum Infrastructure Program, will operate as a 26-bed ...
"LUMEE”, "PROFUSA” and the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia. For more information, visit ...
Explore India's profound cancer burden, with rising incidence and death rates. Join leading experts at the inaugural India ...
In 2025, Mentavi achieved a significant clinical milestone with the peer-reviewed validation of its adult ADHD diagnostic evaluation, demonstrating that its clinician-reviewed, asynchronous assessment ...
The project will transform portions of the 170-acre campus between Midtown and University Circle, though cost estimates and timelines remain undetermined.
“Weight-loss methods, whether with pharmacotherapy or surgery, have to be mindful to avoid inducing these complications,” ...
When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...
Integrating the reverse Aslanger pattern with Littmann’s continuity, the patient was diagnosed with a high lateral, high-risk, occlusive myocardial infarction. The patient immediately received dual ...
A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.
Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results